Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Apr 03, 2026

FEMSA (FMX): Steady Resilience Amid Buybacks and Growth Plans

Key Takeaways

  • FMX shares have shown resilience in recent weeks, trading near the upper end of their 52-week range amid positive corporate actions.
  • Q4 2025 revenues rose 5.7% year-over-year, driven by Proximity Americas growth, though EPS missed estimates.
  • Company completed a $260 million accelerated share repurchase (ASR, a derivative instrument for quick buybacks) and launched a new $300 million program, supporting shareholder value.
  • Shareholders approved dividends and bylaw changes; UBS raised price target to $122, maintaining Buy rating.
  • Restructuring targets MXN 1B in annualized savings, with ambitious 2026 store expansions planned for OXXO Brazil and other markets.
  • Analyst consensus points to moderate upside, with average price target around $117.

Current Market Snapshot

I've been keeping an eye on FMX, and in recent trading sessions, the stock has held a steady upward trajectory, staying near the high end of its 52-week range even with broader market volatility. What stands out to me is the stock's low beta of 0.18, which highlights its defensive qualities, further supported by a robust 5.77% forward dividend yield and consistent capital returns. Investor sentiment seems bolstered by operational momentum in core retail segments like OXXO, as Mexican consumer spending stabilizes at softer levels. Trading volumes have stayed aligned with averages, showing measured interest from institutional holders amid the ongoing share repurchase activity. From what I see, this positions FMX as a resilient option in the consumer staples space during uncertain economic cycles.

Recent Developments Driving FMX Price Action

Fomento Económico Mexicano, S.A.B. de C.V. (FMX), or FEMSA, has managed a combination of positive corporate moves and macroeconomic challenges in recent weeks, leading to stable price performance near multi-month highs. A key factor has been aggressive capital allocation. On March 23, FEMSA completed a $260 million accelerated share repurchase (ASR), buying back approximately 2.5 million American Depositary Shares (ADSs) at an average $104.41 per ADS, with final settlement around March 24. At the same time, the company announced a new $300 million ADS repurchase program, which signals confidence in the stock's undervaluation and has helped lift investor sentiment. These steps are part of a broader $5.3 billion capital return plan through 2026, and they've provided a solid base for share stability, with FMX moving from around $106 in late March to over $114 by early April.

Earlier, the Q4 2025 earnings release on February 25 showed revenue growth of 5.7% to roughly MXN 220 billion, beating estimates, driven by 5.3% increases in Proximity Americas (OXXO stores) revenues and 4.4% same-store sales growth amid recovering traffic. Operating income rose 8.5%, with adjusted EBITDA margins at 14.9%. That said, EPS came in at MXN 24.80, missing estimates by MXN 3.59 due to FX losses and pressures in the health division, including store closures and uncollectibles in Colombia. FMX's Coca-Cola FEMSA unit contributed solid 2.9% revenue growth and record December volumes. New CEO José Antonio Fernández Garza-Lagüera outlined a restructuring plan merging Proximity & Health teams, aiming for MXN 1 billion in annualized savings ramping into 2026, along with taking full ownership of OXXO Brazil. I also checked this using Tickeron’s AI Screener to gauge how FMX stacks up against peers in the industry. These elements contributed to post-earnings firmness.

On March 20, UBS kept its Buy rating and raised its price target to $122 from $109, pointing to rebound potential. At the March 27 shareholder meeting, results for 2025 were approved, along with bylaw changes and dual dividends payable April 23—a proposed 3.7% increase—which further bolsters the yield. Some insider selling by a director (52,316 shares) added mild pressure, but it was overshadowed by the buybacks. Headwinds included softer Mexican traffic from IEPS taxes (federal excise taxes on beverages/snacks) and violence-related OXXO store closures, plus a lawsuit against Circle K (a FEMSA affiliate) over e-cig sales. On the positive side, stabilizing consumer spending and preparations for the FIFA World Cup have helped sentiment. Overall, the buybacks and efficiency efforts have tied to these measured gains, with the low beta helping buffer volatility.

2026 Outlook and Key Factors to Monitor

Looking ahead to 2026 for FEMSA, I'm watching store network expansion and operational efficiencies closely, especially against a soft Mexican consumer environment. Management plans to accelerate OXXO growth with ~100 net new stores in Brazil (>15% increase), a one-third expansion of the Bara base, and 20% growth in Colombia, with a focus on quality execution in São Paulo. OXXO Mexico targets mid-single-digit same-store sales through traffic recovery, better value propositions, and emphasis on breakfast and daily replenishment. The restructuring, including MXN 1B savings from team mergers and Spin fintech integration, should phase in and lift EBITDA margins from 14.9% levels.

Coca-Cola FEMSA's volume momentum, boosted by FIFA World Cup branding, will offset some IEPS tax pressures on high-margin categories. Capital discipline continues with the $5.3B returns through 2026, encompassing buybacks and dividends. Risks include ongoing weak spending, regulatory increases, FX volatility in the peso, and proximity retail competition. Opportunities are in digital loyalty programs, conversions like Delek to OXXO in the U.S. and Europe, and scaling in South America. Consensus points to ~7% revenue growth and 18% earnings expansion, with ROE targeting 14.7%, depending on consumer stabilization and strong execution.

Why I Use Tickeron's Trending AI Robots

In my own research and trading, I often turn to Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI trading bots from hundreds available that analyze and trade thousands of tickers across stocks, ETFs, and crypto. Only the strongest agents—those shining in current conditions based on metrics like annualized returns, win rates, and profit factors—make the cut in this lineup of 25 out of 351 total bots. For instance, some deliver up to +169% annualized returns, win rates as high as 86.54%, and profit factors over 11, focusing on areas like semiconductors, energy, aerospace, and hedging. Each bot has its own approach, from short-term price action on 15-minute charts to multi-agent setups across 25 tickers, with different timeframes and risk levels. This gives me data-driven ways to spot patterns and refine strategies, and I find it particularly useful for stocks like FMX in volatile markets.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: FMX

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for FMX turns negative, indicating new downward trend

FMX saw its Momentum Indicator move below the 0 level on July 28, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned negative. In of the 76 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for FMX turned negative on July 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

FMX moved below its 50-day moving average on August 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for FMX crossed bearishly below the 50-day moving average on August 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where FMX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FMX advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

FMX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 249 cases where FMX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: FMX's P/B Ratio (3.220) is slightly higher than the industry average of (2.177). FMX has a moderately high P/E Ratio (23.404) as compared to the industry average of (17.236). FMX's Projected Growth (PEG Ratio) (4.773) is slightly higher than the industry average of (2.501). Dividend Yield (0.049) settles around the average of (0.037) among similar stocks. P/S Ratio (0.799) is also within normal values, averaging (1.582).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FMX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Anheuser-Busch INBEV SA/NV (NYSE:BUD), Constellation Brands (NYSE:STZ), Molson Coors Beverage Company (NYSE:TAP).

Industry description

The meat, fish, and dairy food industry processes livestock, fish and milk products for consumer consumption. Some companies also process dairy byproducts. Tyson Foods, Inc., Hormel Foods Corporation and Pilgrims Pride Corp. are some of the biggest producers in this industry. Many of these companies are recipients of American farm subsidies. On the other hand, new-age food innovation like plant-based meat substitutes (which are designed to simulate chicken, beef, and pork sausage) could potentially augur disruptions and/or create new competition in this space.

Market Cap

The average market capitalization across the Food: Meat/Fish/Dairy Industry is 39.34B. The market cap for tickers in the group ranges from 317.04K to 154.57B. BUDFF holds the highest valuation in this group at 154.57B. The lowest valued company is ENHD at 317.04K.

High and low price notable news

The average weekly price growth across all stocks in the Food: Meat/Fish/Dairy Industry was 1%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was -7%. CCU experienced the highest price growth at 5%, while STZ experienced the biggest fall at -3%.

Volume

The average weekly volume growth across all stocks in the Food: Meat/Fish/Dairy Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was 65% and the average quarterly volume growth was 19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 24
P/E Growth Rating: 58
Price Growth Rating: 56
SMR Rating: 64
Profit Risk Rating: 80
Seasonality Score: -61 (-100 ... +100)
View a ticker or compare two or three
FMX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a producer of alcoholic and non-alcoholic beverages

Industry FoodMeatFishDairy

Profile
Details
Industry
Beverages Non Alcoholic
Address
General Anaya No. 601 Pte.
Phone
+52 8183286167
Employees
354309
Web
https://www.femsa.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.